Vistagen Therapeutics, Inc.

This study tested an experimental nasal spray (PH94B) to see if it can reduce anxiety in adults with adjustment disorder, a condition where stress from life events causes significant anxiety. 41 adults took the spray or a placebo four times daily for 4 weeks. The goal was to meas…

This Phase 3 trial tested whether a low-dose nasal spray called PH94B can quickly reduce anxiety in adults with social anxiety disorder when they have to speak in public. 224 participants used the spray or a placebo 20 minutes before a short speech and rated their distress. The s…